Patent Yard Sign in
Canadian application, no grantCanada

Stimulation of cartilage growth with agonists of the non-proteolytically activated thrombin receptor

CA 2416404 A1 · Owner: Carney, Darrell H. · Inventors: Carney, Darrell H.; Bergmann, John; Stiernberg, Janet

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

Disclosed is a method of stimulating cartilage growth repair or regeneration , at a site in a subject in need of such growth repair or regeneration. The , method comprises the step of administering a therapeutically effective amount of an agonist of the non-proteolytically activated thrombin receptor to the site. Also disclosed is a method of stimulating the proliferation and expansion of chrondrocytes in vitro. The method comprises culturing chrondrocytes in the presence of a stimulating amount of an NPAR agonist.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed July 19, 2001. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended July 19, 2021.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by July 19, 2023.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledJuly 19, 2001
GrantedNo grant recorded
Term endedJuly 19, 2021
Patent numberCA 2416404 A1
Classification (IPC)A61K38/48 +2 more

Timeline

Timeline From CIPO dates

2002200420062008201020122014201620182020Application filedJuly 19, 2001Term endedJuly 19, 2021

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.